Why CONNEQT

A first-of-its-kind Arterial Health Assessment

CONNEQT is the first clinical-grade arterial assessment that brings professional-level arterial health insights into your home.

Built with 50 years of cardiovascular science and trusted by cardiologists, it goes far beyond traditional blood pressure—tracking your central blood pressure, arterial stiffness, heart stress, and more. Born from breakthrough SphygmoCor® technology, and refined for real-life wellness, CONNEQT delivers life-saving insights—before symptoms show.

$350
Order Now
FSA HSA Eligible
pay over time with affirm
FDA Cleared Solid

Powered by SphygmoCor® Arterial Intelligence™

Built with 50 years of cardiovascular science and trusted by cardiologists, it goes far beyond traditional blood pressure—tracking your central blood pressure, arterial stiffness, heart stress, and more.

Born from breakthrough SphygmoCor® technology, and refined for real-life wellness, CONNEQT delivers life-saving insights—before symptoms show.

parallax background

Now is the time to take the next step for your heart.

You want to know that you're OK.

Why CONNEQT
You want deeper health insights than traditional blood pressure devices provide.

You’re concerned how hypertension impacts your heart, kidneys, and brain.

Why CONNEQT
Why CONNEQT
Why CONNEQT
Why CONNEQT

You want a device backed by cardiologists, validated research, and clinical trials.

You want to track your cardiovascular health over time at home.
Why CONNEQT
You want insights you can trust—clear, personalized, accurate, and reliable.
You’re making lifestyle changes and want to measure your progress.
Why CONNEQT

You’re ready to investigate heart health due to fatigue, circulation issues, or risk signs.

No matter where you are in your heart health journey, CONNEQT's Arterial Health Assessment helps you take control of your future.

More Predictive Data = More Proactive Health

Research-Backed Health Insights

Traditional blood pressure readings only tell part of the story. The Pulse arterial health monitor uses Pulse Wave Analysis (PWA) to measure key vascular biomarkers that predict cardiovascular (CV) risk before symptoms appear.

Results & Clinical Interpretation of CONNEQT Arterial Health Biomarkers

Measurement Central Blood Pressure Central Pulse Pressure Pulse Pressure Amplification Augmentation Pressure Augmentation Index
Threshold >130 mmHg >50 mmHg <130% Each 10 mmHg increase in AP Each 10 % increase in Alx
Risk of Cardiovascular Events 3x
increased
risk of cardiovascular events*		 2-3x
increased
risk of cardiovascular events*		 2-3x
increased
risk of cardiovascular events*		 30%
Increase risk of cardiovascular events*		 35-40%
Increase risk of cardiovascular events*
Scroll to the right >

*Cardiovascular events are defined as a myocardial infarction, coronary revascularization, stroke, heart failure, or cardiovascular mortality.

A 4-mmHg reduction in central pressure can lower cardiovascular risk by 20%. Reductions in arterial stiffness have been shown with ACE-inhibitors, calcium channel blockers, statins, PCSK9 inhibitors, and SGLT2 inhibitors.

By tracking these biomarkers, the Pulse helps detect hidden risks, optimize heart health, and empower better cardiovascular decisions.

parallax background

How CONNEQT compares to other screenings

Scroll to the right >
Test Price Heart Risk Assessed # of Reports In-Home Test
Full-Body MRI Scan Up to $2,500 None One-Time No
Cleerly Heart Scan Up to $1,500 Measures existing coronary artery plaque* One-Time No
Coronary Calcium Scan Up to $500 Measures existing calcium buildup in arteries* One-Time No
DEXA Scan Up to $500 None One-Time No
CONNEQT Arterial Health Assessment $350 Measures and quantifies risk of heart attack, stroke, coronary plaque, and calcification** Recurring Yes
Carotid Artery Screening Up to $300 Detects existing blockages in carotid arteries* One-Time No
Lipid Panel Up to $40 Measures existing cholesterol and triglycerides levels One-Time No

*Does not measure risk of calcification, coronary plaque, or cholesterol.

**CONNEQT measures risk before symptoms arise.

What Our Community Is Saying
  • Member - CONNEQT Enthusiast Facebook Group

    "I’m really enjoying mine. I check my [Pulse] twice a day. As someone with a family history of HBP, the app has been super informative."

    Member - CONNEQT Enthusiast Facebook Group

  • "Combined with a pulse pressure monitor and algorithms, CONNEQT predicts your risk of hardening arteries and heart disease."

    BBC

  • "This device is going to be a game changer... it's like the check engine light going on."

    Dr. Michael Twyman, MD
  • Gizmodo

    "CONNEQT Pulse has the standard inflating arm cuff you’re familiar with, but the level of data it produces goes way beyond just systolic and diastolic pressure."

    GIZMODO
  • Steve J.

    "The CONNEQT Pulse is more than just a blood pressure monitor—it’s a comprehensive cardiovascular health tool."

    Steve J.

  • "What other metrics is your Fitbit or Garmin missing? How about arterial health? "

    WIRED
  • Uwe D.

    "Final Verdict: (5/5) – Highly recommended for proactive heart health management."

    Uwe D.

  • “The holy grail of cardiology, this will transform cardiovascular care”

    SB, Cardiologist
  • David P.

    “I got the device this week, and I love it. My SEVR is low up to 83%  so I am talking to doctors [about it].”

    David P.
  • "The ability for patients to track their own metrics and engage with their cardiovascular health in such a meaningful way is truly remarkable."
    Jorge Perez, Cardiologist
  • Barbara T.

    “I just received my device and I was blown away by all the data it shows on first read."

    Barbara T.
  • "I really like that I can repeat test any time I'd like without having to go to a doctor's office."
    Adam Katz, MIT Data Scientist & Athlete 
  • Jordan W.

    “Great build quality and technology….machine seems to be top-tier."

    Jordan W.
  • Medical Device Executive

    "I have to admit I am impressed"

    Medical Device Executive
  • Morgan B.

    “I've begun to utilize and understand the [Pulse’s] function beyond that of a typical BP reading. It’s been enlightening.”

    Morgan B.
  • Casey M.

    “I just received your Conneqt device and have been playing with it all morning, the user experience is great.”

    Casey M.

Trusted by the world's leading experts

Top 20

All “Top 20 Hospitals” use SphygmoCor technology to measure central blood pressure (cBP)

2,700+

SphygmoCor technology has supported studies that have resulted in over 2,700 peer-reviewed publications.

8/10

8 out of top 10 Pharma companies have used SphygmoCor technology in their clinical trials

11,000

Over 11,000 patients have been tested with SphygmoCor technology in pharmaceutical trials

Cardiologist – HF/PH Specialist

“CONNEQT’s Pulse device has the potential to significantly improve treatment decisions by physicians and the health outcomes of patients through the use of advanced blood pressure and vascular health technologies.”

Dr. Hunter Champion, MD, PhD, FAHA 
Southeastern Cardiology Associates
HF=Heart Failure, PF=Pulmonary Hypertension

Hypertension Specialist

“SphygmoCor has transformed the way we treat hypertension. By using central aortic pressure readings, we can target treatments more precisely, improving patient outcomes without adding complexity to our workflow”

Dr. Mark C. Houston, MD
Director, Hypertension Institute and Vascular Biology
Medical Director of Division of Human Nutrition
Medical Director of Clinical Research
ASH Specialist in Clinical Hypertension (FASH)
Vanderbilt University School of Medicine Associate Clinical Professor of Medicine (1990-2012)

Longevity Specialist

“The CONNEQT Pulse gives a more complete and precise picture of arterial health you can actually act on with dietary and lifestyle changes.”

Dr. Joseph Raffaele, MD
Founder and CEO, Raffaele Medical
American College of Physicians member
American Board of Age Management Medicine Diplomat
Board certified in internal medicine.

Arterial Health Expert

“The CONNEQT PULSE is an easy-to-use, all-in-one device that provides detailed insights of our cardiovascular health”

Dr. Carmel McEniery, PhD
Senior Research Associate, University of Cambridge
Investigator and author of numerous arterial health studies, including Whitehall II (cognition & arterial stiffness), ACCT (vascular aging), and POPPY (pre-eclampsia & cardiovascular health).

Preventive Cardiologist

“This device is going to probably be a game changer for many people who are at high risk or just very interested in their vascular health because this is kind of like the check engine light going on.”

Dr. Michael Twyman, MD
Founder, Apollo Cardiology
Board-certified in Internal Medicine | Heart Attack Prevention Expert
John Cockcroft

Top Cardiology Research Academic

“The Pulse enables healthcare practitioners to obtain unique cardiovascular health insights in order to inform better decision making around treatment. Importantly, the Pulse is also the first device to target widespread adoption of arterial stiffness and central blood pressure as key indicators of cardiovascular health.”

John R. Cockcroft

Dept Advanced Cardiology, 
Columbia University Medical Centre, New York

Vascular and Arterial Health Expert

“CONNEQT’s market leading central aortic pressure technology has been the “gold standard” for over a decade with researchers, specialist clinicians, and pharmaceutical companies in their clinical trials. The “Pulse” now launches that same technology into significant new healthcare markets giving physicians and patients alike deeper insights into cardiovascular health.”

Alberto Avolio
Professor Emeritus – Macquarie Medical School, Macquarie University

Research Backed. Science Driven

In a study of 1100 patients, central pulse pressure was a powerful predictor of major cardiovascular events, while brachial blood pressure was not.

Jankowski et al, Hypertension, 2008

  • “Irrespective of the brachial blood pressure status, central hypertension increased cardiovascular and cerebrovascular risk indicating the importance of controlling central hypertension”​

    Chang, et al, Hypertension, 2022

  • “In a study of 3,500 high risk adults central pulse pressure is 32% better than brachial blood pressure in predicting cardiovascular events”​

    The Strong Heart Study, Roman et al, Hypertension, 2007.

  • Increased vascular stiffness is a predictor of cardiovascular events and all cause mortality independent of traditional cardiovascular risk factors​

    Lancet Commission on Hypertension

  • “You can’t practice hypertension medicine anymore without measuring central blood pressure”​

    Dr. Mark Houston - Director, Hypertension Institute

  • In a study of 2199 patients, central aortic pressure was shown to be a better independent predictor of cardiovascular and kidney outcomes.

    CAFE Study, 2006
Valid Device Listing

Trustworthy Third Party Validation

This product meets the Validated Device Listing (VDL) criteria (as listed on validatebp.org) for validation of clinical accuracy, based on the independent review and acceptance of documentation submitted by the manufacturer.

Backed by Over 50 Years of Research, 20+ Years of Commercial Use, and 5x FDA-Clearances to Date†

FDA Clearances

†SphygmoCor technology.